KRAS and pancreatic neoplasm: Mutant KRAS activates several signaling pathways in the pancreas to reprogram pancreatic acini into pancreatic cancer.65 Transgenic overexpression of KRAS resulted in the development of invasive pancreatic cancer in mice.